Patient Experiences and Perceptions of Living with Refractory Diabetes Mellitus with Insulin Resistance in Japan -A Qualitative Research
Not Applicable
- Conditions
- Insulin resistance, lipoatrophic diabetes mellitus
- Registration Number
- JPRN-UMIN000043693
- Lead Sponsor
- ippon Boehringer Ingelheim Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 4
Inclusion Criteria
Not provided
Exclusion Criteria
-Not eligible at physician's discretion -Patients currently participating in clinical trials on the efficacy and safety of empagliflozin for refractory diabetes mellitus with insulin resistance (conducted by Kobe University with funding and investigational drug provided by Nippon Boehringer Ingelheim [BI] [jRCT2051190029, jRCT2051190094])
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method